tion and platelet reactivity could play an important role in the occurrence of stroke during the acute phase of MI. We aimed to investigate the relationship between the mean platelet volume (MPV), a parameter of platelet function, the C-reactive protein (CRP), and the occurrence of in-hospital ischemic stroke (IHS) after AMI.
tion and platelet reactivity could play an important role in the occurrence of stroke during the acute phase of MI. We aimed to investigate the relationship between the mean platelet volume (MPV), a parameter of platelet function, the C-reactive protein (CRP), and the occurrence of in-hospital ischemic stroke (IHS) after AMI.
Methods: Data were obtained from a French regional survey for AMI, including 5976 patients admitted in intensive care unit (ICU) between 2001 and 2010. Patients were divided in 2 groups according to the occurrence of IHS. MPV, platelet count and CRP were routinely measured from blood samples drawn at admission in ICU. Conclusions: This study describes predictive factors for IHS after AMI, with both higher short and long-term risk of death. At hospital admission, new biological parameters as high MPV/Platelet count ratio and high level of CRP might help to identify patients at increased risk of IHS. Moreover, these results provide new insights on the potential role played by increased inflammation and platelet reactivity underlying the occurrence of stroke after AMI.
Results
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Estimation of small LDL level using the simple precipitation method in Tunisian coronary artery disease patients with and without type 2 diabetes Hanène Aoua (1), Ymène Nekaies (1), Ali Ben Khalfallah (2) Background & objectives: Small dense LDL particles (sdLDL), with greater suceptibility to oxydation, are well-recognized risk marker for coronary artery disease (CAD) and type 2 diabetes mellitus. The aim of the present study sought to separate sdLDL subfraction by heparin-magnesiun precipitation method and to evaluate the possible association of low-density lipoprotein (LDL) particle size CAD and type 2 diabetes mellitus.
Methods:
Forty eight CAD (with or without type 2 diabetes mellitus) patients and 51 apparently healthy subjects were included in this study. sdLDL-cholesterol (sdLDL-C) measured after heparin-magnesiun precipitation. LDL-Cholesterol (LDL-C) was calculated by the Friedwald formula and large, buoyant LDL-Cholesterol (lrgLDL-C) was estimated by subtraction.
Results:
The prevalence of sdLDL was strongly related with the CAD risk level. However, large, buoyant LDL-C showed no significant decrease in CAD patients. LDL-C decreased significantly in CAD without diabetes (CADd-) when compared to controls. Its level significantly lower in CAD with diabetes (CADd+) patients with respect to healthy and to CADdpatients. Small density LDL-C increased significantly in coronary patients (with or without diabetes). However, lrgLDL-C was significantly decreased only in (CADd+) group compared to controls (0.73±0.02 vs 2.02±0.04; p= 0.03 respectively). A negative correlation (r=-0.22, p=0.03) between TG and sdLDL-C levels was observed when all groups are geathred, and was not found in controls and CAD patients (with or without diabetes). No correlation could be evidenced between HDL-C and sdLDL-C concentrations in all groups nor in CAD group.
Conclusions: elevated sdLDL-C level may contribute to atherosclerosis that renforce the developement of coronaropathy. The decrease of lrgLDL seems to be attribuated to diabetes mellitus rather than to CAD. Backgroud: Serum cystatin C has been proposed as a better marker of glomerular filtration rate than serum creatinine. This study aims to evaluate the relationship between cystatinC, BNP and acute coronary syndrome.
Methods: A total of 127 consecutive patients with acute coronary syndrome (ACS) were enrolled in this study. All patients had a normal glomerular filtration rate (GFR) estimated using the MDRD (Modification of Diet in Renal Disease) equation.Serum cystatin C and brain natriuretic peptide (BNP) were determined in all subjects. All patients were followed up for 12 months and adverse cardiovascular events were recorded.
Results: Serum Cys C levels were significantly higher in patients with multi-vessel coronary artery disease (1.17±0.47mg/L vs. 0.93±0.24mg/L, P<0.01). BNP concentrations were significantly associated to left ventricular ejection fraction (LVEF). Patients with systolic heart failure (LVEF < 50%) had higher BNP levels (343.3 pg/mL vs. 212.7 pg/mL; P<0.001). Serum Cys C and BNP levels were significantly associated to mortality and morbidity post ACS. Receiver operator characteristic (ROC) analyses identified cys C as being the best marker in predicting major adverse cardiac and cerebrovascular events (MACCE: heart failure hospitalizations, recurrent ischemic events and mortality) (AUC=0.622). For high Cys C levels (>1.2mg/L), the risk of occurrence of MACCE was multiplied by 3.35 for BNP levels exceeding 350pg/mL. ROC analyses identified BNP as the best predictor of LV systolic dysfunstion (AUC = 0.784). A BNP value exceeding 133pg/mL had a sensibility of 83% and a specificity of 67% for predicting LV systolic dysfunction during follow-up.
Conclusions: Cystatin C and BNP are strong predictors for risk of cardiovascular events in acute coronary syndrome.
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